VA
IBB icon

Valmark Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Valmark Advisers’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Sell
2,360
-75
-3% -$12.9K ﹤0.01% 523
2026
Q1 		$411K Buy
2,435
+75
+3% +$12.8K ﹤0.01% 510
2025
Q4 		$398K Sell
2,360
-132
-5% -$21.4K ﹤0.01% 490
2025
Q3 		$360K Sell
2,492
-81
-3% -$11.1K ﹤0.01% 505
2025
Q2 		$326K Buy
2,573
+139
+6% +$17.1K ﹤0.01% 529
2025
Q1 		$311K Buy
2,434
+892
+58% +$121K ﹤0.01% 510
2024
Q4 		$204K Buy
+1,542
New +$217K ﹤0.01% 585
2024
Q2 		– Sell
-1,622
Closed -$223K – 567
2024
Q1 		$223K Sell
1,622
-37
-2% -$5.05K ﹤0.01% 510
2023
Q4 		$225K Buy
+1,659
New +$202K ﹤0.01% 471
2023
Q3 		– Sell
-1,626
Closed -$206K – 476
2023
Q2 		$206K Buy
1,626
+50
+3% +$6.5K ﹤0.01% 461
2023
Q1 		$204K Buy
+1,576
New +$206K ﹤0.01% 462
2022
Q2 		– Sell
-2,045
Closed -$266K – 417
2022
Q1 		$266K Buy
+2,045
New +$266K ﹤0.01% 382
2021
Q4 		– Sell
-1,376
Closed -$222K – 413
2021
Q3 		$222K Buy
1,376
+1
+0.1% +$168 ﹤0.01% 369
2021
Q2 		$225K Hold
1,375
– – ﹤0.01% 364
2021
Q1 		$207K Buy
+1,375
New +$218K ﹤0.01% 364
2018
Q4 		– Sell
-1,755
Closed -$214K – 206
2018
Q3 		$214K Sell
1,755
-85
-5% -$10K ﹤0.01% 190
2018
Q2 		$202K Buy
+1,840
New +$197K ﹤0.01% 186

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Valmark Advisers's IBB Position: Q2 2026 in Review

Valmark Advisers reduced its iShares Biotechnology ETF (IBB) stake by 3.1% in Q2 2026, selling an estimated $12.9K and leaving 2,360 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

Valmark Advisers first reported a position in IBB in Q2 2018 and has held it in 17 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Valmark Advisers held 2,360 shares of iShares Biotechnology ETF worth $449K as of Q2 2026.
  • Valmark Advisers sold 75 iShares Biotechnology ETF shares in Q2 2026, an estimated $12.9K.
  • iShares Biotechnology ETF made up ﹤0.01% of Valmark Advisers's portfolio in Q2 2026, its #523 holding.
  • Valmark Advisers first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 17 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.